Fig. 1From: A preliminary analysis of interleukin-1 ligands as potential predictive biomarkers of response to cetuximabExpression of IL-1 ligands is elevated in head and neck tumor versus normal tissue. Gene expression of IL1A (a), IL1B (b), and IL1RN (c) from tumor (n = 42) and matched adjacent normal tissue was plotted for available HNSCC patients from the TCGA databaseBack to article page